Skip to main navigation Skip to search Skip to main content

Candidemia y susceptibilidad a antifúngicos en hospitales peruanos

Translated title of the contribution: Candidemia nd antifungal susceptibility in Peruvian hospitals
  • Romina Rios-Blanco
  • , Marcello Olsen-Verme
  • , Fiorella Palomino
  • , Michelle Regal Ludowieg
  • , Jan Jacobs

Research output: Contribution to journalA1: Peer-reviewed journal articlespeer-review

Abstract

Worldwide, Candida bloodstream infections have presented an increase in non-albicans Candida species and resistance to antifungal agents. Objective: To describe the microbiological characteristics of consecutive Candida blood culture isolates. Methods: This study analyzed 73 consecutive Candida blood isolates recovered between July 2017 and July 2019 from routine patient care at 15 Peruvian hospitals, assessing susceptibility to four antifungal agents. Results: The species most frequently detected were Candida parapsilosis 39 (53.4%), Candida albicans 23 (31.5%), and Candida tropicalis 5 (6.8%). Conclusions: All isolates were susceptible to amphotericin B, fluconazole, voriconazole, and anidulafungin. There is a predominance of non-albicans Candida cases in Peru and a high susceptibility to current antifungal drugs.
Translated title of the contributionCandidemia nd antifungal susceptibility in Peruvian hospitals
Original languageSpanish
JournalRevista Médica Herediana
Volume36
Issue number2
Pages (from-to)130-135
Number of pages6
ISSN1018-130X
DOIs
Publication statusPublished - Jun-2025

Fingerprint

Dive into the research topics of 'Candidemia nd antifungal susceptibility in Peruvian hospitals'. Together they form a unique fingerprint.

Cite this